NCT07697313

Brief Summary

To compare High-Intensity Interval Training versus moderate intensity continuous training on gut microbiota in Non- Alcoholic Fatty Liver.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jul 2026Oct 2026

First Submitted

Initial submission to the registry

July 5, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

July 10, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2026

Expected
Last Updated

July 13, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

July 5, 2026

Last Update Submit

July 5, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • assessment of short chain free fatty acids butyrate and acetate

    For short chain free fatty acids analyses, fecal sample will be separated. Applying four analytes, including total Short Chain Fatty Acids, acetate, propionate, and butyrate, will be targeted. Final concentrations will be calculated based on internal standards and are expressed as micromoles per gram of wet feces (μmol/g). Techniques and predictive approaches will be used across. gas chromatography will be used to quantify Short Chain Fatty Acids from fecal samples

    at baseline and after 12 weeks

  • assessment of lipid profile

    Fasting blood samples were collected after an overnight fast, and serum lipid levels were analyzed using standard enzymatic methods with an automated biochemical analyzer. The lipid profile included triglycerides, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol to assess lipid metabolism and cardiovascular risk.

    at baseline and after 12 weeks

Secondary Outcomes (1)

  • assessment of quality of life

    at baseline and after 12 weeks

Study Arms (3)

high intensity interval training and Mediterranean diet

EXPERIMENTAL

This study will involve 20 patients with Non-alcoholic Fatty Liver disease undergoing individualized High-Intensity Interval Training for 12 weeks. The exercise regimen includes 3 sessions per week, featuring 3 sets of 3 minutes of high-intensity intervals at 70-90% heart rate reserve, with 2 minutes of active recovery between intervals. All exercise will be supervised on a treadmill, complemented by a Mediterranean diet.

Other: High intensity interval trainingOther: Mediterranean diet

moderate intensity continous training and Mediterranean diet

EXPERIMENTAL

This group will include 20 patients with non-alcoholic Fatty Liver disease they will receive moderate intensity continous training protocol consisted of 3× 3 min of moderate -intensity intervals at 40- 60% heart rate reserve for 30 min, in addition to Mediterranean diet.

Other: moderate intensity continuous trainingOther: Mediterranean diet

Mediterranean Diet

ACTIVE COMPARATOR

It is characterized by a high consumption of plant-based foods, such as vegetables, fruits, whole grains, seeds, nuts and legumes, and moderate consumption of protein-source foods such as fish and poultry. This diet is rich in monounsaturated fatty acids primarily from olive oil and olives, reduced fat dairy products and low red meat intake.

Other: Mediterranean diet

Interventions

Patients will engage in high-intensity interval training using heart rate reserve (HRR) to determine exercise intensity. The program includes three sessions per week for 12 weeks, featuring three 3-minute high-intensity intervals at 70-90% HRR, with 2 minutes of active recovery in between. Each 30-minute session will be treadmill-based under supervision, incorporating warm-up and cool-down periods. Participants will also follow a Mediterranean diet.

high intensity interval training and Mediterranean diet

The program will be in form of: * Frequency: 3 sessions/week for 12 weeks. * Intensity: Moderate intensity continues training at 40- 60% HRR. * Duration: the session will last 30 minutes per session. Patients will be instructed to follow Mediterranean Diet.

moderate intensity continous training and Mediterranean diet

the composition of the Mediterranean diet, emphasizing that vegetables and fruits make up the largest portion at 35%, followed by whole grains (20%) and fish and seafood (15%). Legumes and nuts account for 10%, while olive oil and dairy products (cheese and yogurt) each contribute 7%. Smaller portions include poultry and eggs (4%) and red meat and sweets (2%), reflecting the diet's focus on plant-based foods, healthy fats, whole grains, and moderate consumption of animal products, with minimal intake of red meat and sugary foods.

Mediterranean Diethigh intensity interval training and Mediterranean dietmoderate intensity continous training and Mediterranean diet

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients from both genders aged 40 - 60 years old diagnosed with Non-alcoholic Fatty Liver disease by ultrasonography.
  • Body mass index will range from 30 to 34.9 kg/m².
  • Patients with central obesity (waist circumference 90 cm for men and 85 cm for women).
  • Patients who have taken no regular exercise in the last year (\<3 times/week and 30 min/time.
  • No antibiotic or probiotic use for at least last 3 months.
  • Medical drugs such as metformin, sulfonylureas, statins, and blood pressure medication were eligible, as well as stable.

You may not qualify if:

  • History of liver cirrhosis or other chronic liver diseases.
  • Use of medications affecting gut microbiota (e.g., laxatives, metformin, proton pump inhibitors).
  • Recent gastrointestinal infections or surgeries.
  • Diabetes Mellitus type 1 or uncontrolled type 2.
  • Cardiovascular, respiratory, or musculoskeletal disorders limiting exercise capacity.
  • Active smokers.
  • Pregnancy or breastfeeding.
  • Uncontrolled hypertension.
  • Communication disorders.
  • Bleeding disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

out-patient clinic, faculty of physical therapy, Horus university

Cairo, Egypt

Location

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

High-Intensity Interval TrainingDiet, Mediterranean

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaDiet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Heba Yasser Bihery, Assistant lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 5, 2026

First Posted

July 13, 2026

Study Start

July 10, 2026

Primary Completion

September 10, 2026

Study Completion (Estimated)

October 10, 2026

Last Updated

July 13, 2026

Record last verified: 2026-07

Locations